Interview with David Mayo in SECAL #76


In the April issue of the SECAL periodical, IDEXX BioAnalytics colleague David Mayo has been interviewed on SECAL membership and the 3R's. Read the original interview in Spanish and below the translated English version.

SECAL interview David Mayo.png

Since when are you members of SECAL and what is your opinion on our association?

We became members of SECAL a year ago and we are very proud of it. Fortunately I have worked in this industry for almost 8 years now (in other companies that were too SECAL beneficiaries), and when I had to decide whether to join or not, I did not hesitate: I truly believe that being members brings great benefits for both parties. 

Why did you think it is important for a company to help SECAL?

Any company in this industry benefits greatly from being part of SECAL, but it is also true that this association benefits from the variety of opinions, representations and positive influences coming from the different companies that are part of it. It is not just what one company provides to the association, but what the whole industry (all companies involved) – and their knowledge of the market, its tendencies, both at national and international level.

How do your products/services contribute to the refinement and better use of laboratory animals?

Quality research comes from combining innovation with efforts to improve the welfare of animals. IDEXX BioAnalytics invests each year more than 15% of its revenue in research and Development programs, and was the first company to come up with a 3R compliant animal health monitoring programme:


  • Offering environmental testing as an alternative
  • Improving the reliability of cell line research


  • Direct quarantine testing, no need for sentinels. Obtain more information from the same source
  • Investigating positive results for possible infectious agents, without the use of additional / extra source material
  • Developing test methods that do not require necropsies, terminal bleeds or sentinels


  • Running complete serology tests with a single drop of blood*
  • Minimise the infection risk as a result of non-tested biological materials
  • Minimising the stress of sample collection and transportation